

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 5.10104157 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 4.52858565 |
| 3 | mesodermal cell differentiation (GO:0048333) | 4.48176743 |
| 4 | skin morphogenesis (GO:0043589) | 4.20943349 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.20850713 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 4.20850713 |
| 7 | substrate-dependent cell migration (GO:0006929) | 4.20443331 |
| 8 | cell-substrate junction assembly (GO:0007044) | 4.01581928 |
| 9 | lung vasculature development (GO:0060426) | 3.98705399 |
| 10 | protein localization to endosome (GO:0036010) | 3.85640210 |
| 11 | endodermal cell differentiation (GO:0035987) | 3.79731305 |
| 12 | regulation of cholesterol storage (GO:0010885) | 3.78389665 |
| 13 | desmosome organization (GO:0002934) | 3.70831687 |
| 14 | wound healing, spreading of epidermal cells (GO:0035313) | 3.70435377 |
| 15 | epithelial cell-cell adhesion (GO:0090136) | 3.61086312 |
| 16 | complement activation, alternative pathway (GO:0006957) | 3.53918365 |
| 17 | barbed-end actin filament capping (GO:0051016) | 3.49819994 |
| 18 | plasma lipoprotein particle clearance (GO:0034381) | 3.48359632 |
| 19 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.46476250 |
| 20 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.45193139 |
| 21 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.43496295 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.36953805 |
| 23 | protein carboxylation (GO:0018214) | 3.36953805 |
| 24 | renal filtration (GO:0097205) | 3.36198862 |
| 25 | hypotonic response (GO:0006971) | 3.34952937 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 3.34934848 |
| 27 | muscle cell migration (GO:0014812) | 3.34514764 |
| 28 | fatty acid transmembrane transport (GO:1902001) | 3.31495118 |
| 29 | phospholipid homeostasis (GO:0055091) | 3.31119161 |
| 30 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.31001190 |
| 31 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.26672966 |
| 32 | protein retention in ER lumen (GO:0006621) | 3.26364779 |
| 33 | positive regulation of odontogenesis (GO:0042482) | 3.26203140 |
| 34 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.22260561 |
| 35 | endothelial cell morphogenesis (GO:0001886) | 3.21910402 |
| 36 | regulation of protein activation cascade (GO:2000257) | 3.19249949 |
| 37 | lysine catabolic process (GO:0006554) | 3.17025463 |
| 38 | lysine metabolic process (GO:0006553) | 3.17025463 |
| 39 | positive regulation of p38MAPK cascade (GO:1900745) | 3.16939103 |
| 40 | positive regulation of extracellular matrix organization (GO:1903055) | 3.16655956 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.14221870 |
| 42 | wound healing, spreading of cells (GO:0044319) | 3.13639411 |
| 43 | regulation of complement activation (GO:0030449) | 3.13129740 |
| 44 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.12897638 |
| 45 | alpha-linolenic acid metabolic process (GO:0036109) | 3.12764156 |
| 46 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.12694063 |
| 47 | membrane raft organization (GO:0031579) | 3.12358229 |
| 48 | hyaluronan catabolic process (GO:0030214) | 3.09029947 |
| 49 | positive regulation of lipid storage (GO:0010884) | 3.08506260 |
| 50 | regulation of sequestering of triglyceride (GO:0010889) | 3.06846519 |
| 51 | positive regulation of osteoblast proliferation (GO:0033690) | 3.06530496 |
| 52 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.04228064 |
| 53 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.00245443 |
| 54 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.00245443 |
| 55 | positive regulation of receptor recycling (GO:0001921) | 3.00164801 |
| 56 | atrioventricular valve morphogenesis (GO:0003181) | 2.99499996 |
| 57 | actin filament depolymerization (GO:0030042) | 2.98954153 |
| 58 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.98458106 |
| 59 | adherens junction assembly (GO:0034333) | 2.98064280 |
| 60 | cell-substrate adherens junction assembly (GO:0007045) | 2.97387611 |
| 61 | focal adhesion assembly (GO:0048041) | 2.97387611 |
| 62 | endothelium development (GO:0003158) | 2.96892617 |
| 63 | carnitine shuttle (GO:0006853) | 2.96413304 |
| 64 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.95662428 |
| 65 | sulfur amino acid catabolic process (GO:0000098) | 2.95069966 |
| 66 | endocardial cushion development (GO:0003197) | 2.94895250 |
| 67 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.93325197 |
| 68 | cysteine metabolic process (GO:0006534) | 2.93197718 |
| 69 | lymphangiogenesis (GO:0001946) | 2.91982990 |
| 70 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.91767498 |
| 71 | semaphorin-plexin signaling pathway (GO:0071526) | 2.88934005 |
| 72 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.87971255 |
| 73 | positive regulation of blood coagulation (GO:0030194) | 2.87709120 |
| 74 | positive regulation of hemostasis (GO:1900048) | 2.87709120 |
| 75 | negative regulation of lipid storage (GO:0010888) | 2.86583157 |
| 76 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.86063271 |
| 77 | blood vessel maturation (GO:0001955) | 2.85752826 |
| 78 | glyoxylate metabolic process (GO:0046487) | 2.85506601 |
| 79 | stress fiber assembly (GO:0043149) | 2.84957693 |
| 80 | fatty acid beta-oxidation (GO:0006635) | 2.84775805 |
| 81 | regulation of metalloenzyme activity (GO:0048552) | 2.83173762 |
| 82 | L-phenylalanine metabolic process (GO:0006558) | 2.82655076 |
| 83 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.82655076 |
| 84 | 2-oxoglutarate metabolic process (GO:0006103) | 2.82194771 |
| 85 | regulation of cardioblast differentiation (GO:0051890) | 2.81334270 |
| 86 | regulation of triglyceride catabolic process (GO:0010896) | 2.81218020 |
| 87 | valine metabolic process (GO:0006573) | 2.80938338 |
| 88 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.80248111 |
| 89 | endothelial cell chemotaxis (GO:0035767) | 2.79340605 |
| 90 | cell adhesion mediated by integrin (GO:0033627) | 2.78890448 |
| 91 | regulation of glomerular filtration (GO:0003093) | 2.78882068 |
| 92 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.78072342 |
| 93 | regulation of cholesterol homeostasis (GO:2000188) | 2.77960452 |
| 94 | regulation of fibrinolysis (GO:0051917) | 2.75627085 |
| 95 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.75398626 |
| 96 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.75227530 |
| 97 | membrane protein ectodomain proteolysis (GO:0006509) | 2.73974686 |
| 98 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.73458065 |
| 99 | L-phenylalanine catabolic process (GO:0006559) | 2.73458065 |
| 100 | positive regulation of coagulation (GO:0050820) | 2.73402124 |
| 101 | fatty acid oxidation (GO:0019395) | 2.71546623 |
| 102 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.70954290 |
| 103 | urea cycle (GO:0000050) | 2.70927656 |
| 104 | urea metabolic process (GO:0019627) | 2.70927656 |
| 105 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.70664922 |
| 106 | amino-acid betaine metabolic process (GO:0006577) | 2.68283347 |
| 107 | iron ion import (GO:0097286) | 2.68181890 |
| 108 | protein maturation by protein folding (GO:0022417) | 2.67791717 |
| 109 | positive regulation of epithelial cell migration (GO:0010634) | 2.67624129 |
| 110 | type B pancreatic cell proliferation (GO:0044342) | 2.67530348 |
| 111 | lipid oxidation (GO:0034440) | 2.66505506 |
| 112 | negative regulation of fatty acid transport (GO:2000192) | 2.66217193 |
| 113 | * apoptotic cell clearance (GO:0043277) | 2.65678261 |
| 114 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.65473114 |
| 115 | regulation of p38MAPK cascade (GO:1900744) | 2.63550484 |
| 116 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.63130624 |
| 117 | acute-phase response (GO:0006953) | 2.61625238 |
| 118 | fibrinolysis (GO:0042730) | 2.60290178 |
| 119 | extracellular fibril organization (GO:0043206) | 2.59227656 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 2.58721443 |
| 121 | lung lobe morphogenesis (GO:0060463) | 2.58340836 |
| 122 | growth hormone receptor signaling pathway (GO:0060396) | 2.58201251 |
| 123 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.58157768 |
| 124 | homocysteine metabolic process (GO:0050667) | 2.57847786 |
| 125 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.57074984 |
| 126 | surfactant homeostasis (GO:0043129) | 2.56617141 |
| 127 | acylglycerol homeostasis (GO:0055090) | 2.56054309 |
| 128 | triglyceride homeostasis (GO:0070328) | 2.56054309 |
| 129 | ethanol oxidation (GO:0006069) | 2.55696316 |
| 130 | kynurenine metabolic process (GO:0070189) | 2.55114504 |
| 131 | extracellular matrix disassembly (GO:0022617) | 2.55019274 |
| 132 | positive regulation of fatty acid oxidation (GO:0046321) | 2.54639923 |
| 133 | protein hydroxylation (GO:0018126) | 2.53696062 |
| 134 | negative regulation of anoikis (GO:2000811) | 2.53271969 |
| 135 | reverse cholesterol transport (GO:0043691) | 2.52942109 |
| 136 | positive regulation of endothelial cell migration (GO:0010595) | 2.52936038 |
| 137 | carnitine metabolic process (GO:0009437) | 2.50634914 |
| 138 | sarcomere organization (GO:0045214) | 2.50563299 |
| 139 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.50304980 |
| 140 | pinocytosis (GO:0006907) | 2.49819996 |
| 141 | chondrocyte proliferation (GO:0035988) | 2.49624480 |
| 142 | collagen metabolic process (GO:0032963) | 2.49415491 |
| 143 | negative regulation of cartilage development (GO:0061037) | 2.49289417 |
| 144 | platelet degranulation (GO:0002576) | 2.48656997 |
| 145 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.48317476 |
| 146 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.47365106 |
| 147 | positive regulation by symbiont of host defense response (GO:0052509) | 2.47184837 |
| 148 | modulation by symbiont of host defense response (GO:0052031) | 2.47184837 |
| 149 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.47184837 |
| 150 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.47184837 |
| 151 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.47184837 |
| 152 | modulation by symbiont of host immune response (GO:0052553) | 2.47184837 |
| 153 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.46730949 |
| 154 | regulation of lipid storage (GO:0010883) | 2.46642686 |
| 155 | high-density lipoprotein particle remodeling (GO:0034375) | 2.46532069 |
| 156 | nitrogen cycle metabolic process (GO:0071941) | 2.45787181 |
| 157 | regulation of fatty acid oxidation (GO:0046320) | 2.44823051 |
| 158 | venous blood vessel morphogenesis (GO:0048845) | 2.44585077 |
| 159 | gap junction assembly (GO:0016264) | 2.44543489 |
| 160 | cellular response to vitamin D (GO:0071305) | 2.42626781 |
| 161 | fatty acid catabolic process (GO:0009062) | 2.42617861 |
| 162 | aromatic amino acid family catabolic process (GO:0009074) | 2.41481086 |
| 163 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.41075309 |
| 164 | positive regulation of adherens junction organization (GO:1903393) | 2.41051705 |
| 165 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.40656979 |
| 166 | carnitine transmembrane transport (GO:1902603) | 2.40000931 |
| 167 | carnitine transport (GO:0015879) | 2.39609542 |
| 168 | amino-acid betaine transport (GO:0015838) | 2.39609542 |
| 169 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.39508004 |
| 170 | tricarboxylic acid metabolic process (GO:0072350) | 2.39239424 |
| 171 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.38226210 |
| 172 | cell junction assembly (GO:0034329) | 2.37976556 |
| 173 | fibril organization (GO:0097435) | 2.37880129 |
| 174 | cell volume homeostasis (GO:0006884) | 2.37617772 |
| 175 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.37249892 |
| 176 | positive regulation of cartilage development (GO:0061036) | 2.37019079 |
| 177 | peptidyl-proline hydroxylation (GO:0019511) | 2.36929774 |
| 178 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.36792919 |
| 179 | basement membrane organization (GO:0071711) | 2.34840079 |
| 180 | regulation of plasminogen activation (GO:0010755) | 2.34829264 |
| 181 | lipoprotein metabolic process (GO:0042157) | 2.34726552 |
| 182 | detection of molecule of bacterial origin (GO:0032490) | 2.31936335 |
| 183 | phospholipid efflux (GO:0033700) | 2.31670326 |
| 184 | cholesterol homeostasis (GO:0042632) | 2.31085332 |
| 185 | sterol homeostasis (GO:0055092) | 2.30839714 |
| 186 | brown fat cell differentiation (GO:0050873) | 2.28665380 |
| 187 | negative regulation of protein autophosphorylation (GO:0031953) | 2.27958784 |
| 188 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.27893297 |
| 189 | acetyl-CoA metabolic process (GO:0006084) | 2.27772456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.42590739 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.21984663 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.04405580 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.64900724 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.42573054 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.23256329 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.87203767 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.81443769 |
| 9 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.75756752 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.70896852 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.70896563 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.67566577 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.50511192 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.43828682 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.36469855 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.36411752 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.27670277 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.25871713 |
| 19 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19363976 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.19065971 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.07377836 |
| 22 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.00667492 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.99963524 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.98286739 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.92166395 |
| 26 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84715248 |
| 27 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.84453415 |
| 28 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82120813 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.76485575 |
| 30 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75693416 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.74019333 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73730156 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68161358 |
| 34 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67440444 |
| 35 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.65804260 |
| 36 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64743614 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63029065 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.62807002 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59543986 |
| 40 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.55452943 |
| 41 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.54626473 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.51878207 |
| 43 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.51563064 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51400785 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48668138 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48148621 |
| 47 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.48049755 |
| 48 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.46909004 |
| 49 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42197519 |
| 50 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.42030020 |
| 51 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.38714774 |
| 52 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.38714774 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38293959 |
| 54 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.38156544 |
| 55 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.37296440 |
| 56 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35952140 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32935193 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32891916 |
| 59 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32243388 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31618968 |
| 61 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.24140410 |
| 62 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23372342 |
| 63 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22865454 |
| 64 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20585707 |
| 65 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.20246851 |
| 66 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19162045 |
| 67 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.18741793 |
| 68 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.18729653 |
| 69 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18726964 |
| 70 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18679311 |
| 71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15771018 |
| 72 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.15457293 |
| 73 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14750360 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.14466032 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12546837 |
| 76 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.12079084 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11684847 |
| 78 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.11400674 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09637335 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09624898 |
| 81 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09492013 |
| 82 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08590726 |
| 83 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.07287044 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07204554 |
| 85 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.07166366 |
| 86 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.07166366 |
| 87 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.06428533 |
| 88 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06356476 |
| 89 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06044308 |
| 90 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05618256 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05484662 |
| 92 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05163232 |
| 93 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03757608 |
| 94 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03606918 |
| 95 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03050448 |
| 96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03023768 |
| 97 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02810513 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00210907 |
| 99 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99981486 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99802186 |
| 101 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99713428 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99564557 |
| 103 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.98789130 |
| 104 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98772291 |
| 105 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98576837 |
| 106 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98051351 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97629989 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96899677 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96738209 |
| 110 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96454211 |
| 111 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95807266 |
| 112 | MAF_26560356_Chip-Seq_TH1_Human | 0.95403321 |
| 113 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95175731 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94658224 |
| 115 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94213492 |
| 116 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93951980 |
| 117 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93897410 |
| 118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93563111 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92907566 |
| 120 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.92514556 |
| 121 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92240321 |
| 122 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.92116009 |
| 123 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91563567 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91019945 |
| 125 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90915496 |
| 126 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90235118 |
| 127 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89446045 |
| 128 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.88894129 |
| 129 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87565895 |
| 130 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87302672 |
| 131 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.86839360 |
| 132 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.85771359 |
| 133 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.85141682 |
| 134 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84851886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.20062840 |
| 2 | MP0005360_urolithiasis | 3.01855258 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 2.76895680 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.69206825 |
| 5 | MP0005365_abnormal_bile_salt | 2.54011089 |
| 6 | MP0003950_abnormal_plasma_membrane | 2.49578519 |
| 7 | MP0005623_abnormal_meninges_morphology | 2.42801520 |
| 8 | MP0010368_abnormal_lymphatic_system | 2.36455604 |
| 9 | MP0009840_abnormal_foam_cell | 2.34572068 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.31777065 |
| 11 | MP0003724_increased_susceptibility_to | 2.29963151 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.25881398 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.17631028 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.15368927 |
| 15 | MP0005257_abnormal_intraocular_pressure | 2.10950921 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.06190154 |
| 17 | MP0004084_abnormal_cardiac_muscle | 2.03112165 |
| 18 | MP0010329_abnormal_lipoprotein_level | 1.92748918 |
| 19 | MP0004130_abnormal_muscle_cell | 1.92676481 |
| 20 | MP0004510_myositis | 1.89429528 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.86407367 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 1.84461288 |
| 23 | MP0003303_peritoneal_inflammation | 1.81426086 |
| 24 | MP0001849_ear_inflammation | 1.77668757 |
| 25 | MP0003252_abnormal_bile_duct | 1.77398326 |
| 26 | * MP0003566_abnormal_cell_adhesion | 1.68003540 |
| 27 | MP0005670_abnormal_white_adipose | 1.67801089 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.66000637 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.65621367 |
| 30 | MP0002254_reproductive_system_inflammat | 1.62652629 |
| 31 | MP0003828_pulmonary_edema | 1.62641370 |
| 32 | MP0001958_emphysema | 1.60666005 |
| 33 | MP0003436_decreased_susceptibility_to | 1.60481822 |
| 34 | MP0005083_abnormal_biliary_tract | 1.57396785 |
| 35 | MP0004858_abnormal_nervous_system | 1.56379867 |
| 36 | MP0001879_abnormal_lymphatic_vessel | 1.56273746 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.48362741 |
| 38 | * MP0000343_altered_response_to | 1.46574043 |
| 39 | MP0000609_abnormal_liver_physiology | 1.44954029 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.43826744 |
| 41 | MP0004272_abnormal_basement_membrane | 1.42741583 |
| 42 | MP0006054_spinal_hemorrhage | 1.42517779 |
| 43 | MP0005451_abnormal_body_composition | 1.41715847 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.41601982 |
| 45 | MP0002060_abnormal_skin_morphology | 1.40784905 |
| 46 | MP0000858_altered_metastatic_potential | 1.38091585 |
| 47 | MP0010030_abnormal_orbit_morphology | 1.37853805 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.37497394 |
| 49 | MP0009278_abnormal_bone_marrow | 1.36266087 |
| 50 | MP0005409_darkened_coat_color | 1.35813659 |
| 51 | MP0002896_abnormal_bone_mineralization | 1.34109046 |
| 52 | MP0005330_cardiomyopathy | 1.33766929 |
| 53 | MP0005275_abnormal_skin_tensile | 1.32512638 |
| 54 | MP0002295_abnormal_pulmonary_circulatio | 1.31522868 |
| 55 | MP0009785_altered_susceptibility_to | 1.31175658 |
| 56 | MP0004036_abnormal_muscle_relaxation | 1.31039888 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.30529010 |
| 58 | MP0005332_abnormal_amino_acid | 1.28352850 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.26807561 |
| 60 | MP0005595_abnormal_vascular_smooth | 1.25943866 |
| 61 | MP0000537_abnormal_urethra_morphology | 1.25697218 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 1.25369003 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 1.23443553 |
| 64 | MP0004019_abnormal_vitamin_homeostasis | 1.21711057 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.21521498 |
| 66 | MP0000678_abnormal_parathyroid_gland | 1.21216553 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.21200366 |
| 68 | MP0000762_abnormal_tongue_morphology | 1.17769000 |
| 69 | MP0000751_myopathy | 1.17560717 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.16061978 |
| 71 | MP0009643_abnormal_urine_homeostasis | 1.15806948 |
| 72 | MP0005023_abnormal_wound_healing | 1.15267700 |
| 73 | MP0010630_abnormal_cardiac_muscle | 1.14595820 |
| 74 | MP0004233_abnormal_muscle_weight | 1.13877090 |
| 75 | MP0001666_abnormal_nutrient_absorption | 1.12427885 |
| 76 | MP0002933_joint_inflammation | 1.12267621 |
| 77 | MP0000003_abnormal_adipose_tissue | 1.12226144 |
| 78 | MP0000733_abnormal_muscle_development | 1.11646460 |
| 79 | MP0000249_abnormal_blood_vessel | 1.11126488 |
| 80 | MP0008469_abnormal_protein_level | 1.10928364 |
| 81 | MP0000750_abnormal_muscle_regeneration | 1.10902319 |
| 82 | * MP0002419_abnormal_innate_immunity | 1.10603188 |
| 83 | MP0001915_intracranial_hemorrhage | 1.10431674 |
| 84 | MP0005197_abnormal_uvea_morphology | 1.10196291 |
| 85 | MP0005508_abnormal_skeleton_morphology | 1.09879703 |
| 86 | MP0005375_adipose_tissue_phenotype | 1.08439246 |
| 87 | MP0004947_skin_inflammation | 1.08156277 |
| 88 | MP0000534_abnormal_ureter_morphology | 1.07894986 |
| 89 | MP0005164_abnormal_response_to | 1.07637748 |
| 90 | * MP0001544_abnormal_cardiovascular_syste | 1.06638215 |
| 91 | * MP0005385_cardiovascular_system_phenoty | 1.06638215 |
| 92 | MP0001614_abnormal_blood_vessel | 1.06416136 |
| 93 | MP0001835_abnormal_antigen_presentation | 1.05121837 |
| 94 | MP0000767_abnormal_smooth_muscle | 1.04852252 |
| 95 | * MP0009764_decreased_sensitivity_to | 1.04663466 |
| 96 | MP0004087_abnormal_muscle_fiber | 1.02880708 |
| 97 | MP0002972_abnormal_cardiac_muscle | 1.01865835 |
| 98 | MP0003075_altered_response_to | 1.01662701 |
| 99 | MP0005025_abnormal_response_to | 1.00914763 |
| 100 | MP0003329_amyloid_beta_deposits | 1.00722623 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 1.00488075 |
| 102 | MP0000604_amyloidosis | 1.00281334 |
| 103 | MP0003941_abnormal_skin_development | 0.99949216 |
| 104 | MP0005503_abnormal_tendon_morphology | 0.99773370 |
| 105 | MP0000685_abnormal_immune_system | 0.99040081 |
| 106 | MP0006138_congestive_heart_failure | 0.98604282 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.97218147 |
| 108 | MP0003279_aneurysm | 0.96972477 |
| 109 | MP0000467_abnormal_esophagus_morphology | 0.96011021 |
| 110 | MP0009053_abnormal_anal_canal | 0.95174381 |
| 111 | MP0002925_abnormal_cardiovascular_devel | 0.95112726 |
| 112 | MP0000749_muscle_degeneration | 0.94702968 |
| 113 | MP0005165_increased_susceptibility_to | 0.93782411 |
| 114 | MP0010352_gastrointestinal_tract_polyps | 0.93318390 |
| 115 | MP0004215_abnormal_myocardial_fiber | 0.91409781 |
| 116 | MP0001348_abnormal_lacrimal_gland | 0.90513667 |
| 117 | MP0002971_abnormal_brown_adipose | 0.90454387 |
| 118 | MP0003186_abnormal_redox_activity | 0.89533373 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89510325 |
| 120 | MP0002168_other_aberrant_phenotype | 0.89270329 |
| 121 | MP0000598_abnormal_liver_morphology | 0.89037176 |
| 122 | MP0008004_abnormal_stomach_pH | 0.86495277 |
| 123 | MP0006082_CNS_inflammation | 0.86397194 |
| 124 | MP0004883_abnormal_blood_vessel | 0.85739426 |
| 125 | MP0002998_abnormal_bone_remodeling | 0.85664919 |
| 126 | MP0001853_heart_inflammation | 0.85599150 |
| 127 | * MP0009763_increased_sensitivity_to | 0.85306147 |
| 128 | * MP0001845_abnormal_inflammatory_respons | 0.84484830 |
| 129 | MP0001542_abnormal_bone_strength | 0.84213043 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.83859543 |
| 131 | MP0003091_abnormal_cell_migration | 0.83076296 |
| 132 | MP0005390_skeleton_phenotype | 0.82948110 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.82499559 |
| 134 | MP0005166_decreased_susceptibility_to | 0.82029406 |
| 135 | MP0001790_abnormal_immune_system | 0.81790463 |
| 136 | MP0005387_immune_system_phenotype | 0.81790463 |
| 137 | MP0010155_abnormal_intestine_physiology | 0.81740392 |
| 138 | MP0003646_muscle_fatigue | 0.81566170 |
| 139 | MP0002128_abnormal_blood_circulation | 0.81229237 |
| 140 | MP0005076_abnormal_cell_differentiation | 0.80716295 |
| 141 | MP0003195_calcinosis | 0.79091830 |
| 142 | MP0009384_cardiac_valve_regurgitation | 0.79079395 |
| 143 | * MP0003448_altered_tumor_morphology | 0.75401247 |
| 144 | MP0002796_impaired_skin_barrier | 0.74301943 |
| 145 | MP0003045_fibrosis | 0.73267085 |
| 146 | MP0000759_abnormal_skeletal_muscle | 0.73077411 |
| 147 | MP0001243_abnormal_dermal_layer | 0.71172487 |
| 148 | MP0002332_abnormal_exercise_endurance | 0.69507041 |
| 149 | MP0005501_abnormal_skin_physiology | 0.68976357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 5.63634794 |
| 2 | Arterial tortuosity (HP:0005116) | 5.04621580 |
| 3 | Vascular tortuosity (HP:0004948) | 4.78666102 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.10592382 |
| 5 | Atrophic scars (HP:0001075) | 3.93178124 |
| 6 | Cervical subluxation (HP:0003308) | 3.87779195 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 3.83526766 |
| 8 | Distal lower limb amyotrophy (HP:0008944) | 3.59474187 |
| 9 | Complement deficiency (HP:0004431) | 3.53900838 |
| 10 | Esophageal varix (HP:0002040) | 3.49553585 |
| 11 | Vertebral compression fractures (HP:0002953) | 3.40804955 |
| 12 | Xanthomatosis (HP:0000991) | 3.40618857 |
| 13 | Distal lower limb muscle weakness (HP:0009053) | 3.25640198 |
| 14 | Polycythemia (HP:0001901) | 3.23833463 |
| 15 | Short nail (HP:0001799) | 3.23655882 |
| 16 | Fragile skin (HP:0001030) | 3.22753801 |
| 17 | Myocardial infarction (HP:0001658) | 3.18397090 |
| 18 | Asymmetric septal hypertrophy (HP:0001670) | 3.08888315 |
| 19 | Joint hemorrhage (HP:0005261) | 3.08821780 |
| 20 | Distal upper limb amyotrophy (HP:0007149) | 3.08100047 |
| 21 | Upper limb amyotrophy (HP:0009129) | 3.08100047 |
| 22 | Increased connective tissue (HP:0009025) | 3.06514542 |
| 23 | Broad face (HP:0000283) | 3.05331711 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.05182661 |
| 25 | Ventricular tachycardia (HP:0004756) | 2.99193257 |
| 26 | Intrahepatic cholestasis (HP:0001406) | 2.92350462 |
| 27 | Spinal rigidity (HP:0003306) | 2.90469209 |
| 28 | Hematochezia (HP:0002573) | 2.90096757 |
| 29 | Wormian bones (HP:0002645) | 2.83881202 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 2.83379792 |
| 31 | Abnormality of complement system (HP:0005339) | 2.80041337 |
| 32 | Muscle fiber splitting (HP:0003555) | 2.76892674 |
| 33 | Cerebral aneurysm (HP:0004944) | 2.76496253 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.76018073 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.68620044 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.67621449 |
| 37 | Sudden death (HP:0001699) | 2.64534103 |
| 38 | Spondylolisthesis (HP:0003302) | 2.64293985 |
| 39 | Interstitial pulmonary disease (HP:0006530) | 2.59189052 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 2.59177393 |
| 41 | Hyporeflexia of lower limbs (HP:0002600) | 2.56534274 |
| 42 | Focal segmental glomerulosclerosis (HP:0000097) | 2.53315478 |
| 43 | Hypoglycemic coma (HP:0001325) | 2.51493415 |
| 44 | Hyperammonemia (HP:0001987) | 2.50099338 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.48609493 |
| 46 | Hyperlipoproteinemia (HP:0010980) | 2.48418351 |
| 47 | Lower limb amyotrophy (HP:0007210) | 2.48103558 |
| 48 | Aortic aneurysm (HP:0004942) | 2.47387523 |
| 49 | Difficulty climbing stairs (HP:0003551) | 2.45698530 |
| 50 | Ankle contracture (HP:0006466) | 2.45343777 |
| 51 | Abnormality of proline metabolism (HP:0010907) | 2.44628138 |
| 52 | Hydroxyprolinuria (HP:0003080) | 2.44628138 |
| 53 | Tetraparesis (HP:0002273) | 2.42756740 |
| 54 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.42456316 |
| 55 | Amyloidosis (HP:0011034) | 2.42358631 |
| 56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.41147026 |
| 57 | Nephritis (HP:0000123) | 2.36334008 |
| 58 | Menorrhagia (HP:0000132) | 2.35470399 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.35165853 |
| 60 | Hypolipoproteinemia (HP:0010981) | 2.33857466 |
| 61 | Dilatation of the ascending aorta (HP:0005111) | 2.32397468 |
| 62 | Wrist flexion contracture (HP:0001239) | 2.31429509 |
| 63 | Exercise-induced muscle cramps (HP:0003710) | 2.31037715 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.30363838 |
| 65 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.30297501 |
| 66 | Increased cerebral lipofuscin (HP:0011813) | 2.30245945 |
| 67 | Myoglobinuria (HP:0002913) | 2.29503934 |
| 68 | Shallow orbits (HP:0000586) | 2.29197044 |
| 69 | Ketosis (HP:0001946) | 2.29141204 |
| 70 | Glucose intolerance (HP:0000833) | 2.28311467 |
| 71 | Lipoatrophy (HP:0100578) | 2.27068896 |
| 72 | Axonal loss (HP:0003447) | 2.26236720 |
| 73 | Eczematoid dermatitis (HP:0000976) | 2.26145459 |
| 74 | Hemorrhage of the eye (HP:0011885) | 2.25086474 |
| 75 | Bladder diverticulum (HP:0000015) | 2.24477134 |
| 76 | Flat acetabular roof (HP:0003180) | 2.23440362 |
| 77 | Mitral stenosis (HP:0001718) | 2.23368639 |
| 78 | Blue sclerae (HP:0000592) | 2.20985855 |
| 79 | Aortic dissection (HP:0002647) | 2.20882192 |
| 80 | Abnormality of the acetabulum (HP:0003170) | 2.19858725 |
| 81 | Hyperacusis (HP:0010780) | 2.18124424 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 2.17821977 |
| 83 | Aneurysm (HP:0002617) | 2.17715441 |
| 84 | Skin nodule (HP:0200036) | 2.17341644 |
| 85 | Nuclear cataract (HP:0100018) | 2.16363878 |
| 86 | Hyperglycinuria (HP:0003108) | 2.15130339 |
| 87 | Milia (HP:0001056) | 2.14537094 |
| 88 | Cardiovascular calcification (HP:0011915) | 2.13818471 |
| 89 | Glomerulonephritis (HP:0000099) | 2.12314334 |
| 90 | Vascular calcification (HP:0004934) | 2.11744876 |
| 91 | Hypercholesterolemia (HP:0003124) | 2.11356345 |
| 92 | Glomerulosclerosis (HP:0000096) | 2.11118369 |
| 93 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.11031198 |
| 94 | Epidermoid cyst (HP:0200040) | 2.10957680 |
| 95 | Ketoacidosis (HP:0001993) | 2.10489521 |
| 96 | Abnormality of the intrinsic pathway (HP:0010989) | 2.10368013 |
| 97 | Coxa vara (HP:0002812) | 2.09457308 |
| 98 | Osteolytic defects of the hand bones (HP:0009699) | 2.09027894 |
| 99 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09027894 |
| 100 | Nausea (HP:0002018) | 2.08884262 |
| 101 | Trismus (HP:0000211) | 2.07348983 |
| 102 | Lymphangioma (HP:0100764) | 2.05511084 |
| 103 | Autoimmune thrombocytopenia (HP:0001973) | 2.04346724 |
| 104 | Gingival bleeding (HP:0000225) | 2.03996921 |
| 105 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.02850299 |
| 106 | Neonatal death (HP:0003811) | 2.02718072 |
| 107 | Prolonged partial thromboplastin time (HP:0003645) | 2.01819138 |
| 108 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.01475657 |
| 109 | Joint stiffness (HP:0001387) | 2.01229128 |
| 110 | Aortic regurgitation (HP:0001659) | 2.00458282 |
| 111 | Facial diplegia (HP:0001349) | 1.98118884 |
| 112 | Elbow flexion contracture (HP:0002987) | 1.97689814 |
| 113 | Broad metatarsal (HP:0001783) | 1.97643942 |
| 114 | Hand muscle atrophy (HP:0009130) | 1.96040087 |
| 115 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95717518 |
| 116 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95717518 |
| 117 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95717518 |
| 118 | Disproportionate tall stature (HP:0001519) | 1.94909881 |
| 119 | Conjunctival telangiectasia (HP:0000524) | 1.94431515 |
| 120 | Mitral regurgitation (HP:0001653) | 1.94355882 |
| 121 | Alopecia of scalp (HP:0002293) | 1.94245790 |
| 122 | Increased serum ferritin (HP:0003281) | 1.93452183 |
| 123 | Onycholysis (HP:0001806) | 1.93340715 |
| 124 | Vacuolated lymphocytes (HP:0001922) | 1.93203608 |
| 125 | Abnormality of dentin (HP:0010299) | 1.93074533 |
| 126 | Abnormality of oral frenula (HP:0000190) | 1.92801303 |
| 127 | Palpitations (HP:0001962) | 1.92427038 |
| 128 | Hypobetalipoproteinemia (HP:0003563) | 1.90352013 |
| 129 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90214616 |
| 130 | Mucopolysacchariduria (HP:0008155) | 1.90214616 |
| 131 | Ulnar bowing (HP:0003031) | 1.90067705 |
| 132 | Hypertriglyceridemia (HP:0002155) | 1.89492148 |
| 133 | Abnormality of iron homeostasis (HP:0011031) | 1.88597542 |
| 134 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88548201 |
| 135 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88548201 |
| 136 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88548201 |
| 137 | Mitral valve prolapse (HP:0001634) | 1.87945277 |
| 138 | Increased variability in muscle fiber diameter (HP:0003557) | 1.87928321 |
| 139 | Peritonitis (HP:0002586) | 1.87768877 |
| 140 | Gout (HP:0001997) | 1.87046140 |
| 141 | Achilles tendon contracture (HP:0001771) | 1.86921979 |
| 142 | Premature rupture of membranes (HP:0001788) | 1.86804062 |
| 143 | Type 1 muscle fiber predominance (HP:0003803) | 1.86313955 |
| 144 | Abnormal cartilage morphology (HP:0002763) | 1.85347951 |
| 145 | Increased mean platelet volume (HP:0011877) | 1.84153866 |
| 146 | Joint laxity (HP:0001388) | 1.83991951 |
| 147 | Natal tooth (HP:0000695) | 1.83901098 |
| 148 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83514019 |
| 149 | Rhabdomyolysis (HP:0003201) | 1.82692638 |
| 150 | Ankyloglossia (HP:0010296) | 1.82227431 |
| 151 | Visceral angiomatosis (HP:0100761) | 1.82213414 |
| 152 | Stroke (HP:0001297) | 1.82104958 |
| 153 | Aortic valve stenosis (HP:0001650) | 1.81946942 |
| 154 | Thrombophlebitis (HP:0004418) | 1.81502679 |
| 155 | Dysostosis multiplex (HP:0000943) | 1.81490042 |
| 156 | Spastic diplegia (HP:0001264) | 1.80402775 |
| 157 | Atrial fibrillation (HP:0005110) | 1.79746076 |
| 158 | Long toe (HP:0010511) | 1.79712551 |
| 159 | Abnormality of glycine metabolism (HP:0010895) | 1.79529619 |
| 160 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.79529619 |
| 161 | Hepatocellular carcinoma (HP:0001402) | 1.79316903 |
| 162 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.79075058 |
| 163 | Neurofibrillary tangles (HP:0002185) | 1.76847355 |
| 164 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74861513 |
| 165 | Abnormality of the Achilles tendon (HP:0005109) | 1.73530677 |
| 166 | Abnormal ossification of hand bones (HP:0005921) | 1.73038825 |
| 167 | Bradycardia (HP:0001662) | 1.72356021 |
| 168 | Striae distensae (HP:0001065) | 1.72333713 |
| 169 | Hydroureter (HP:0000072) | 1.71934169 |
| 170 | Spinal cord compression (HP:0002176) | 1.70892814 |
| 171 | Thin bony cortex (HP:0002753) | 1.70848998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.77127709 |
| 2 | ERN1 | 3.43512906 |
| 3 | TIE1 | 3.38866717 |
| 4 | TTN | 3.17919374 |
| 5 | TGFBR2 | 3.01928673 |
| 6 | PKN2 | 2.83021378 |
| 7 | KDR | 2.50829719 |
| 8 | NTRK1 | 2.36252235 |
| 9 | RIPK1 | 2.28521705 |
| 10 | EPHB1 | 2.08949670 |
| 11 | TESK1 | 2.03213103 |
| 12 | TBK1 | 2.01932432 |
| 13 | FGFR4 | 1.97167644 |
| 14 | MYLK | 1.93116558 |
| 15 | LIMK1 | 1.92836855 |
| 16 | BCKDK | 1.90807562 |
| 17 | SIK1 | 1.83254732 |
| 18 | PTK6 | 1.77963861 |
| 19 | TYK2 | 1.65315315 |
| 20 | MAP3K3 | 1.63509985 |
| 21 | MAP2K3 | 1.53233569 |
| 22 | MST1R | 1.48215220 |
| 23 | EPHA2 | 1.45845310 |
| 24 | CAMK1D | 1.44474658 |
| 25 | LATS2 | 1.42919356 |
| 26 | JAK1 | 1.33726996 |
| 27 | IRAK3 | 1.33522550 |
| 28 | PDGFRA | 1.32054153 |
| 29 | MAP3K14 | 1.30991248 |
| 30 | JAK3 | 1.26353043 |
| 31 | MAP4K1 | 1.26058928 |
| 32 | DMPK | 1.25297373 |
| 33 | LRRK2 | 1.24944872 |
| 34 | NEK9 | 1.24727868 |
| 35 | TAOK3 | 1.24309843 |
| 36 | LMTK2 | 1.21388857 |
| 37 | CSK | 1.19945493 |
| 38 | CDC42BPA | 1.13865791 |
| 39 | NME2 | 1.12571888 |
| 40 | BMX | 1.10404197 |
| 41 | SMG1 | 1.05376997 |
| 42 | EPHA3 | 1.01400762 |
| 43 | CDK8 | 1.01113102 |
| 44 | STK38 | 1.00607213 |
| 45 | LATS1 | 1.00524568 |
| 46 | KIT | 1.00134957 |
| 47 | JAK2 | 0.99104231 |
| 48 | TRPM7 | 0.98056301 |
| 49 | PAK4 | 0.96807877 |
| 50 | IKBKE | 0.95587405 |
| 51 | FLT3 | 0.95534307 |
| 52 | STK10 | 0.95111368 |
| 53 | TGFBR1 | 0.93174537 |
| 54 | ARAF | 0.92624300 |
| 55 | MAP3K11 | 0.92314977 |
| 56 | DDR2 | 0.90785065 |
| 57 | FGFR3 | 0.87855073 |
| 58 | PRKG2 | 0.86465632 |
| 59 | ROCK2 | 0.85620513 |
| 60 | FER | 0.84160072 |
| 61 | PTK2 | 0.83605583 |
| 62 | EPHB2 | 0.82897952 |
| 63 | ZAP70 | 0.81862289 |
| 64 | MAP3K10 | 0.80072805 |
| 65 | MOS | 0.78637944 |
| 66 | MET | 0.78263487 |
| 67 | PRKAA2 | 0.77644627 |
| 68 | CAMK1G | 0.77387531 |
| 69 | PDK2 | 0.74686880 |
| 70 | MATK | 0.74192900 |
| 71 | ROCK1 | 0.73266393 |
| 72 | GSK3A | 0.72219520 |
| 73 | MAP3K7 | 0.71307755 |
| 74 | PRKD2 | 0.71282942 |
| 75 | CDK6 | 0.67778143 |
| 76 | PRPF4B | 0.67739644 |
| 77 | MAPKAPK3 | 0.67252839 |
| 78 | RPS6KA2 | 0.66662349 |
| 79 | ABL2 | 0.65611710 |
| 80 | PDK3 | 0.65277776 |
| 81 | PDK4 | 0.65277776 |
| 82 | BLK | 0.64728383 |
| 83 | PRKD1 | 0.63993926 |
| 84 | MAP3K6 | 0.62476458 |
| 85 | PIM2 | 0.62414580 |
| 86 | OBSCN | 0.61606109 |
| 87 | PIK3CG | 0.61588661 |
| 88 | TESK2 | 0.61024772 |
| 89 | PTK2B | 0.60993003 |
| 90 | PIK3CA | 0.60759258 |
| 91 | EEF2K | 0.60456125 |
| 92 | MAP3K12 | 0.60372042 |
| 93 | PAK2 | 0.60035844 |
| 94 | IKBKB | 0.58999539 |
| 95 | RPS6KA4 | 0.58830185 |
| 96 | CHUK | 0.58694410 |
| 97 | EGFR | 0.58646201 |
| 98 | PDGFRB | 0.58152187 |
| 99 | MAP2K2 | 0.57375465 |
| 100 | MAPK11 | 0.57284924 |
| 101 | SCYL2 | 0.56815361 |
| 102 | FGR | 0.54819291 |
| 103 | MAP3K2 | 0.54496681 |
| 104 | STK3 | 0.54084329 |
| 105 | PDPK1 | 0.53059818 |
| 106 | CAMK2G | 0.52991679 |
| 107 | MAP3K1 | 0.52493389 |
| 108 | STK24 | 0.51874124 |
| 109 | MTOR | 0.51343998 |
| 110 | ERBB4 | 0.49654634 |
| 111 | MAP2K1 | 0.48806384 |
| 112 | TAOK2 | 0.47819599 |
| 113 | ICK | 0.47814045 |
| 114 | PHKG2 | 0.47682560 |
| 115 | PHKG1 | 0.47682560 |
| 116 | RET | 0.47621501 |
| 117 | MELK | 0.46455549 |
| 118 | ILK | 0.46394045 |
| 119 | DAPK3 | 0.45955794 |
| 120 | MAP3K8 | 0.45481946 |
| 121 | RPS6KA6 | 0.44889254 |
| 122 | MAPK12 | 0.44769486 |
| 123 | HCK | 0.44075127 |
| 124 | CAMK2D | 0.42600162 |
| 125 | MAP3K13 | 0.41510207 |
| 126 | RPS6KC1 | 0.40456092 |
| 127 | RPS6KL1 | 0.40456092 |
| 128 | MAPK4 | 0.38792169 |
| 129 | PAK1 | 0.36715393 |
| 130 | HIPK2 | 0.36073578 |
| 131 | GRK7 | 0.34035215 |
| 132 | CDK9 | 0.33685547 |
| 133 | * SRC | 0.33486296 |
| 134 | MARK2 | 0.32975593 |
| 135 | MAPKAPK2 | 0.32612799 |
| 136 | CAMK2B | 0.32507503 |
| 137 | MST4 | 0.28335711 |
| 138 | KSR2 | 0.26796709 |
| 139 | MAPK7 | 0.25323075 |
| 140 | MAP3K9 | 0.22830204 |
| 141 | ADRBK1 | 0.18851002 |
| 142 | CLK1 | 0.18835996 |
| 143 | KSR1 | 0.17774438 |
| 144 | AKT2 | 0.17561604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.69392629 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.68818384 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.66630775 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56356565 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.55460329 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.37851589 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.36853059 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.22789122 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.16304017 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14016073 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.08299474 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.04920838 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98503793 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92525727 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90413779 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81634709 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.68302349 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.65646981 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59731327 |
| 20 | Bladder cancer_Homo sapiens_hsa05219 | 1.51722517 |
| 21 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.50414279 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42200793 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.37574912 |
| 24 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.35914430 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.35513581 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.29729511 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28813723 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28368385 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.27992334 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.27425552 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24092370 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23732352 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.21942594 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.21835071 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21447251 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 1.21385002 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21019432 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.14684417 |
| 39 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.14203890 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14075513 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13652451 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11450067 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10472217 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09469729 |
| 45 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07019175 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06710184 |
| 47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.06171365 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06009763 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05916376 |
| 50 | Insulin resistance_Homo sapiens_hsa04931 | 1.03703067 |
| 51 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.00988636 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99864453 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99566958 |
| 54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99225438 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.98336172 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97826798 |
| 57 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.97777765 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.97476078 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.97097514 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.96261549 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.93693512 |
| 62 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93356601 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.92513097 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91824869 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89583644 |
| 66 | Focal adhesion_Homo sapiens_hsa04510 | 0.88988617 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.88914096 |
| 68 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.88558694 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87617394 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86314804 |
| 71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85972105 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83354859 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83179047 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.82286674 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81488862 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81346507 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81340598 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80937416 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80558293 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.80137096 |
| 81 | Pathways in cancer_Homo sapiens_hsa05200 | 0.78790577 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78507811 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78068697 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.76988021 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74596294 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73588437 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73099651 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71456980 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71423343 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70299622 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69544766 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68235424 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68116535 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.66264942 |
| 95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66257497 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66018991 |
| 97 | Axon guidance_Homo sapiens_hsa04360 | 0.65574514 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65140272 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64161128 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63950731 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63834599 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62778945 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59761557 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.59760504 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57720665 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57687241 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57115735 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57057788 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55912350 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54997905 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54852088 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54334434 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.52748427 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52452284 |
| 115 | Glioma_Homo sapiens_hsa05214 | 0.50939028 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50401381 |
| 117 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49892698 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.49267261 |
| 119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48388320 |
| 120 | Gap junction_Homo sapiens_hsa04540 | 0.48142339 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47532573 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.46642766 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46635649 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46558098 |
| 125 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.46423526 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46089941 |
| 127 | Melanoma_Homo sapiens_hsa05218 | 0.44953698 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.44639250 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.44584053 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44053874 |
| 131 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44023480 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43736360 |
| 133 | Platelet activation_Homo sapiens_hsa04611 | 0.43687759 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43649239 |
| 135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43483881 |
| 136 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43228202 |
| 137 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42810380 |
| 138 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42304777 |
| 139 | Influenza A_Homo sapiens_hsa05164 | 0.41383841 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40899634 |
| 141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40596889 |
| 142 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40160372 |
| 143 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.39525879 |
| 144 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39153408 |
| 145 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36566210 |

